首页 | 本学科首页   官方微博 | 高级检索  
检索        

MDS转化为AML机制的研究进展
引用本文:王淋淋,高冲,陈宝安.MDS转化为AML机制的研究进展[J].中国实验血液学杂志,2011,19(1):254-259.
作者姓名:王淋淋  高冲  陈宝安
作者单位:东南大学医学院中大医院血液科,江苏,南京,210009
摘    要:骨髓增生异常综合症(MDS)是造血干细胞克隆性疾病,以无效造血和可转变为急性白血病为特征,大约有30%的病例可转变成急性白血病.这种转变则在高危的MDS患者中更为常见,故又称为继发性急性髓系白血病(sAML或MDS/AML).化疗对这类疾病-般很难奏效,唯-治愈的方法就是异基因造血干细胞移植,但是只有很少的病人适合移植.所以,对MDS发生和发展的机制研究和为临床开发其有效药物显得特别重要.本文将从染色体异常、DNA异常甲基化和AMLI/RUNXI,FLT- 3,PI-PLCβ1基因突变这三个方面进行介绍.

关 键 词:染色体异常  DNA  甲基化

Research Progress on Mechanism of MDS Transformation into AML——Review
WANG Lin-Lin,GAO Chong,CHEN Bao-An.Research Progress on Mechanism of MDS Transformation into AML——Review[J].Journal of Experimental Hematology,2011,19(1):254-259.
Authors:WANG Lin-Lin  GAO Chong  CHEN Bao-An
Institution:WANG Lin-Lin,GAO Chong,CHEN Bao-An Department of Hematology,Zhongda Hospital,Southeast University Clinical Medical College,Nanjing 210009,Jiangsu Province,China
Abstract:Myelodysplastic syndrome(MDS) is a clonal hematopoietic stem cell disorder characterized by ineffective hematopoiesis and a risk of transformation into acute leukemia.Approximately 30% of patients with MDS will progress and develop into acute myeloid leukemia(AML),especially in the patients with high-risk MDS,which can be named as secondary acute myeloid leukemia(sAML or MDS/AML).Generally,chemotherapy for sAML hardly has any efficacy.The only way to cure the patients with sAML is allogeneic hematopoietic s...
Keywords:MDS  AML
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号